
Matthew Rettig MD
Associate Professor, Medicine, UCLA School of Medicine
Join to View Full Profile
11301 Wilshire Blvd., 111HLos Angeles, CA 90073
Phone+1 310-268-3622
Fax+1 310-268-3622
Dr. Rettig is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1993 - 1996
- University of WashingtonResidency, Internal Medicine, 1991 - 1993
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Internship, Internal Medicine, 1990 - 1991
- Duke University School of MedicineClass of 1990
Certifications & Licensure
- CA State Medical License 1993 - 2027
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A 2 Part, Phase 2 Trial of Galeterone in the Treatment of Castration Resistant Prostate Cancer Start of enrollment: 2012 Dec 01
- Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC
- Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate Cancer Start of enrollment: 2014 Sep 23
- Join now to see all
Publications & Presentations
PubMed
- Early changes of PSMA PET expression after initiation of androgen receptor signaling inhibitors in CRPC: an international multicenter retrospective study.Lena M Unterrainer, Andrea Farolfi, Tristan Grogan, Masatoshi Hotta, Loïc Djaileb
European Journal of Nuclear Medicine and Molecular Imaging. 2025-03-26 - Phase I, First-in-Human Study of FOR46 (FG-3246), an Immune-Modulating Antibody-Drug Conjugate Targeting CD46, in Patients With Metastatic Castration-Resistant Prostat...Rahul R Aggarwal, Jacqueline Vuky, David VanderWeele, Matthew Rettig, Elisabeth I Heath
Journal of Clinical Oncology. 2025-03-26 - Correction: Hao et al. Enhanced Chemoprevention of Prostate Cancer by Combining Arctigenin with Green Tea and Quercetin in Prostate-Specific Phosphatase and Tensin Hom...Qiongyu Hao, Susanne M Henning, Clara E Magyar, Jonathan Said, Jin Zhong
Biomolecules. 2025-01-21
Journal Articles
- Functional Profiling of Circulating Tumor Cells with an Integrated Vortex Capture and Single-Cell Protease Activity AssaySteven M Dubinett, Matthew B Rettig, Proceedings of the National Academy of Sciences
Press Mentions
- Landmark VA Study Uncovers Gene Variant Linked to Prostate CancerFebruary 19th, 2025
- INmune Bio Inc. Expands INKmune Trial in Prostate Cancer to VeteransJanuary 28th, 2025
- INmune Bio Inc. Expands INKmune Trial in Prostate Cancer to VeteransJanuary 28th, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: